Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency

Immunodeficiency

Interstitial lung disease in patients with Common Variable Immunodeficiency Disorders: several different pathologies?

Clin Exp Immunol.

Patel S, Anzilotti C, Lucas M, Moore N, Chapel H

doi: 10.1111/cei.13343.

Further Publications Rheumatology

Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis

Rheumatology (Oxford)

Goswami RP, Ray A, Chatterjee M, Mukherjee A, Sircar G, Ghosh P

doi: 10.1093/rheumatology/keaa550

Rheumatoid Arthritis

Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry

Rheumatology (Oxford).

Vadillo C, Nieto MA, Romero-Bueno F, Leon L, Sanchez-Pernaute O, Rodriguez-Nieto MJ, Freites D, Jover JA, Álvarez-Sala JL, Abasolo L

doi: 10.1093/rheumatology/kez673.

EULAR ^® 2020

Interstitial Lung Diseases

Systemic Sclerosis

Hemodynamic response to treatment and outcome in pulmonary hypertension associated with interstitial lung disease versus pulmonary arterial hypertension in systemic sclerosis

Arthritis Rheumatol.

Chauvelot L, Gamondes D, Berthiller J, Nieves A, Renard S, Catella-Chatron J, Ahmad K, Bertoletti L, Camara B, Gomez E, Launay D, Montani D, Mornex JF, Prévot G, Sanchez O, Schott AM, Subtil F, Traclet J, Turquier S, Zeghmar S, Habib G, Reynaud-Gaubert M, Humbert M, Cottin V

doi: 10.1002/art.41512.

EULAR ^® 2019

Systemic Sclerosis-Associated Interstitial Lung Disease

Distler et al. 2019. Nintedanib reduced decline in forced vital capacity across subgroups of patients with systemic sclerosis-associated interstitial lung disease: Data from the SENSCIS trial. Oral presentation presented at: EULAR 2019 Congress; 12–15 June 2019; Madrid, Spain.

Immunodeficiency

Inflammatory Bowel Disease in Chronic Granulomatous Disease: an emerging problem over a twenty years' experience

Pediatr Allergy Immunol.

Angelino G, De Angelis P, Faraci S, Rea F, Romeo EF, Torroni F, Tambucci R, Claps A, Francalanci P, Chiriaco M, Di Matteo G, Cancrini C, Palma P, D'Argenio P, Dall'Oglio L, Rossi P, Finocchi A

doi: 10.1111/pai.12814.

Immunodeficiency

Differentiation of Common Variable Immunodeficiency from Igg Deficiency

J Allergy Clin Immunol Pract.

Filion CA, Taylor-Black S, Maglione PJ, Radigan L, Cunningham-Rundles C

doi: 10.1016/j.jaip.2018.12.004.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease

Semin Arthritis Rheum.

Romero-Bueno F, Diaz Del Campo P, Trallero-Araguás E, Ruiz-Rodríguez JC, Castellvi I, Rodriguez-Nieto MJ, Martínez-Becerra MJ, Sanchez-Pernaute O, Pinal-Fernandez I, Solanich X, Gono T, Gonzalez-Gay MA, Plana MN, Selva-O'Callaghan A, MEDRA5 (Spanish MDA5 Register) group (listed contributors at the end of the article)

doi: 10.1016/j.semarthrit.

Related content

Interstitial lung disease in patients with Common Variable Immunodeficiency Disorders: several different pathologies?

Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis

Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry

Interstitial Lung Diseases

Hemodynamic response to treatment and outcome in pulmonary hypertension associated with interstitial lung disease versus pulmonary arterial hypertension in systemic sclerosis

Systemic Sclerosis-Associated Interstitial Lung Disease

Inflammatory Bowel Disease in Chronic Granulomatous Disease: an emerging problem over a twenty years' experience

Differentiation of Common Variable Immunodeficiency from Igg Deficiency

Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease